• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式

Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.

作者信息

Yamamoto Akitaka, Wada Hideo, Tomida Masaki, Ichikawa Yuhuko, Ezaki Minoru, Shiraki Katsuya, Shimaoka Motomu, Iba Toshiaki, Suzuki-Inoue Katsue, Kawamura Masahide, Shimpo Hideto

机构信息

Department of Emergency and Critical Care Center, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.

Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.

出版信息

Diagnostics (Basel). 2023 Jul 6;13(13):2299. doi: 10.3390/diagnostics13132299.

DOI:10.3390/diagnostics13132299
PMID:37443690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341221/
Abstract

UNLABELLED

The scoring systems for disseminated intravascular coagulation (DIC) criteria require several adequate cutoff values, vary, and are complicated. Accordingly, a simpler and quicker diagnostic method for DIC is needed. Under such circumstances, soluble C-type lectin-like receptor 2 (sCLEC-2) received attention as a biomarker for platelet activation.

MATERIALS AND METHODS

The diagnostic usefulness of sCLEC-2 and several formulas, including sCLEC-2xD-dimer, sCLEC-2/platelet count (sCLEC-2/PLT), and sCLEC-2/PLT × D-dimer (sCLEC-2xD-dimer/PLT), were evaluated among 38 patients with DIC, 39 patients with pre-DIC and 222 patients without DIC or pre-DIC (non-DIC).

RESULTS

Although the plasma level of sCLEC-2 alone was not a strong biomarker for the diagnosis of DIC or pre-DIC, the sCLEC-2xD-dimer/PLT values in patients with DIC were significantly higher than those in patients without DIC, and in a receiver operating characteristic (ROC) analysis for the diagnosis of DIC, sCLEC-2xD-dimer/PLT showed the highest AUC, sensitivity, and odds ratio. This formula is useful for the diagnosis of both pre-DIC and DIC. sCLEC-2xD-dimer/PLT values were significantly higher in non-survivors than in survivors.

CONCLUSION

The sCLEC-2xD-dimer/PLT formula is simple, easy, and highly useful for the diagnosis of DIC and pre-DIC without the use of a scoring system.

摘要

未标注

弥散性血管内凝血(DIC)标准的评分系统需要几个合适的临界值,且各不相同,较为复杂。因此,需要一种更简单、快速的DIC诊断方法。在这种情况下,可溶性C型凝集素样受体2(sCLEC-2)作为血小板活化的生物标志物受到关注。

材料与方法

在38例DIC患者、39例DIC前期患者和222例无DIC或DIC前期(非DIC)患者中,评估了sCLEC-2以及几种公式,包括sCLEC-2×D-二聚体、sCLEC-2/血小板计数(sCLEC-2/PLT)和sCLEC-2/PLT×D-二聚体(sCLEC-2×D-二聚体/PLT)的诊断价值。

结果

虽然单独的sCLEC-2血浆水平不是诊断DIC或DIC前期的强大生物标志物,但DIC患者的sCLEC-2×D-二聚体/PLT值显著高于非DIC患者,并且在诊断DIC的受试者工作特征(ROC)分析中,sCLEC-2×D-二聚体/PLT显示出最高的曲线下面积(AUC)、敏感性和比值比。该公式对DIC前期和DIC的诊断均有用。非幸存者的sCLEC-2×D-二聚体/PLT值显著高于幸存者。

结论

sCLEC-2×D-二聚体/PLT公式简单、易行,在不使用评分系统的情况下对DIC和DIC前期的诊断非常有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/e3b574158894/diagnostics-13-02299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/b243e9b3f2fb/diagnostics-13-02299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/8fa27b0e6781/diagnostics-13-02299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/42f2b1b07f12/diagnostics-13-02299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/146ee3edfe1a/diagnostics-13-02299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/e3b574158894/diagnostics-13-02299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/b243e9b3f2fb/diagnostics-13-02299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/8fa27b0e6781/diagnostics-13-02299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/42f2b1b07f12/diagnostics-13-02299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/146ee3edfe1a/diagnostics-13-02299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d24/10341221/e3b574158894/diagnostics-13-02299-g005.jpg

相似文献

1
Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.利用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式
Diagnostics (Basel). 2023 Jul 6;13(13):2299. doi: 10.3390/diagnostics13132299.
2
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.可溶性C型凝集素样受体2是弥散性血管内凝血的生物标志物。
J Clin Med. 2021 Jun 28;10(13):2860. doi: 10.3390/jcm10132860.
3
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.采用 C2PAC 指数早期识别脓毒症诱导的凝血功能障碍:可溶性 C 型凝集素样受体 2(sCLEC-2)水平与血小板计数的比值。
Platelets. 2022 Aug 18;33(6):935-944. doi: 10.1080/09537104.2021.2019694. Epub 2022 Jan 24.
4
Detection of Thrombosis Using Soluble C-Type Lectin-like Receptor-2 with D-Dimer Level and Platelet Count.利用可溶性C型凝集素样受体-2结合D-二聚体水平和血小板计数检测血栓形成
J Clin Med. 2024 Oct 8;13(19):5980. doi: 10.3390/jcm13195980.
5
What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299.可溶性C型凝集素样受体2(sCLEC-2)×D-二聚体/血小板(PLT)(sCLEC-2×D-二聚体/PLT)对凝血/纤溶状态意味着什么?对山本等人的评论。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年,,2299。
Diagnostics (Basel). 2023 Dec 25;14(1):41. doi: 10.3390/diagnostics14010041.
6
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299".对石仓浩的回复。可溶性C型凝集素样受体2(sCLEC-2)×D-二聚体/血小板(PLT)(sCLEC-2×D-二聚体/PLT)对凝血/纤溶状态意味着什么?对“山本等人。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年,,2299”的评论。
Diagnostics (Basel). 2023 Dec 25;14(1):42. doi: 10.3390/diagnostics14010042.
7
Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.可溶性 C 型凝集素样受体 2×D-二聚体在急性脑梗死患者中的超公式。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241232858. doi: 10.1177/10760296241232858.
8
Efficacy evaluation of D-dimer and modified criteria in overt and nonovert disseminated intravascular coagulation diagnosis.D - 二聚体及改良标准在显性和非显性弥散性血管内凝血诊断中的疗效评估
Int J Lab Hematol. 2016 Apr;38(2):151-9. doi: 10.1111/ijlh.12467. Epub 2016 Feb 2.
9
Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation.弥散性血管内凝血快速诊断标准的建议。
J Clin Med. 2022 Feb 16;11(4):1028. doi: 10.3390/jcm11041028.
10
Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction.急性脑梗死患者可溶性C型凝集素样受体2升高
J Clin Med. 2021 Jul 30;10(15):3408. doi: 10.3390/jcm10153408.

引用本文的文献

1
Detection of Thrombosis Using Soluble C-Type Lectin-like Receptor-2 with D-Dimer Level and Platelet Count.利用可溶性C型凝集素样受体-2结合D-二聚体水平和血小板计数检测血栓形成
J Clin Med. 2024 Oct 8;13(19):5980. doi: 10.3390/jcm13195980.
2
Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.可溶性 C 型凝集素样受体 2×D-二聚体在急性脑梗死患者中的超公式。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241232858. doi: 10.1177/10760296241232858.
3
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299".

本文引用的文献

1
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.C 型凝集素样受体 2 水平与血小板计数比值(C2PAC)升高有助于 IDH 野生型脑胶质瘤术后静脉血栓栓塞症的诊断。
Thromb Res. 2023 Mar;223:36-43. doi: 10.1016/j.thromres.2023.01.018. Epub 2023 Jan 21.
2
Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis.国际血栓与止血学会科学与标准化委员会关于脓毒症管理中脓毒症诱导的凝血障碍的通讯。
J Thromb Haemost. 2023 Jan;21(1):145-153. doi: 10.1016/j.jtha.2022.10.022. Epub 2022 Dec 22.
3
对石仓浩的回复。可溶性C型凝集素样受体2(sCLEC-2)×D-二聚体/血小板(PLT)(sCLEC-2×D-二聚体/PLT)对凝血/纤溶状态意味着什么?对“山本等人。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年,,2299”的评论。
Diagnostics (Basel). 2023 Dec 25;14(1):42. doi: 10.3390/diagnostics14010042.
4
What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299.可溶性C型凝集素样受体2(sCLEC-2)×D-二聚体/血小板(PLT)(sCLEC-2×D-二聚体/PLT)对凝血/纤溶状态意味着什么?对山本等人的评论。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年,,2299。
Diagnostics (Basel). 2023 Dec 25;14(1):41. doi: 10.3390/diagnostics14010041.
C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
C 型凝集素样受体(CLEC)-2 是 podoplanin 的配体,可诱导足细胞发生形态变化。
Sci Rep. 2022 Dec 26;12(1):22356. doi: 10.1038/s41598-022-26456-9.
4
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al.“新冠病毒引发的非传统CD147依赖性血小板激活在新冠肺炎中的作用”:和田等人的评论
J Thromb Haemost. 2022 Sep;20(9):2159-2160. doi: 10.1111/jth.15791.
5
Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome.肾病综合征患者可溶性 podoplanin 升高与高凝状态相关。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221108967. doi: 10.1177/10760296221108967.
6
Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation.弥散性血管内凝血快速诊断标准的建议。
J Clin Med. 2022 Feb 16;11(4):1028. doi: 10.3390/jcm11041028.
7
Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019.血浆可溶性C型凝集素样受体2升高与2019冠状病毒病病情恶化相关。
J Clin Med. 2022 Feb 14;11(4):985. doi: 10.3390/jcm11040985.
8
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.采用 C2PAC 指数早期识别脓毒症诱导的凝血功能障碍:可溶性 C 型凝集素样受体 2(sCLEC-2)水平与血小板计数的比值。
Platelets. 2022 Aug 18;33(6):935-944. doi: 10.1080/09537104.2021.2019694. Epub 2022 Jan 24.
9
Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy.脓毒症诱导的凝血病及国际血栓与止血协会评分系统在新型冠状病毒肺炎相关弥散性血管内凝血中的诊断和预后价值
J Res Med Sci. 2021 Oct 18;26:102. doi: 10.4103/jrms.JRMS_1295_20. eCollection 2021.
10
Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction.急性脑梗死患者可溶性C型凝集素样受体2升高
J Clin Med. 2021 Jul 30;10(15):3408. doi: 10.3390/jcm10153408.